Why does Wells Fargo see value in the Apogee acquisition?

Analysts believe the acquisition enhances shareholder value through strategic expansion.

What is AbbVie's dividend growth rate?

The 5-year average dividend growth rate is 6.33%.

Wells Fargo Maintains Overweight on ABBV With $260 Target

Wells Fargo maintained an Overweight rating on AbbVie (ABBV) and set a $260 price target, seeing value in the Apogee acquisition. AbbVie is among the top 11 Dividend Kings with a 6.33% dividend growth rate.

June 23, 2026

2 min read

Source: Insider Monkey

Key Numbers

price target

$260

dividend growth rate

6.33%

Wells Fargo reiterated its Overweight rating on AbbVie Inc. (NYSE:ABBV) and set a $260 price target on the shares, according to a report from Insider Monkey on June 22.

Rating Change

The bank kept its positive rating unchanged, with a new price target of $260, implying upside from current trading levels.

Analyst Rationale

Wells Fargo analysts view AbbVie's acquisition of Apogee as a value-enhancing strategic move. AbbVie is also among the top 11 Dividend Kings with a 5-year average dividend growth rate of 6.33%.

Context

No other analyst ratings were mentioned in the report. However, the stock's recent performance and stable dividend policy make it attractive for income investors.

Conclusion

Wells Fargo's reaffirmation reflects confidence in AbbVie's growth-through-acquisition strategy and strong dividend profile. Investors are advised to conduct their own assessment of risks and opportunities.

Frequently Asked Questions

The price target is $260 per share.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.